Key facts
- This page summarizes Eugene Bauer's Form 4 filing for Evommune, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 11 Dec 2025, 16:18.
Eugene Bauer - 09 Dec 2025 Form 4 Insider Report for Evommune, Inc.
- Signature
- /s/ Gregory S. Moss, Attorney-in-Fact
- Issuer symbol
- EVMN on NYSE
- Transactions as of
- 09 Dec 2025
- Net transaction value
- -$26,368
- Form type
- 4
- Filing time
- 11 Dec 2025, 16:18:49 UTC
- Previous filing
- 19 Dec 2025
- Next filing
- 17 Apr 2026
- SEC filing
- View on sec.gov
Reporting owner
2 facts
Issuer context
1 fact
Transaction snapshot
2 facts
SEC evidence
5 facts
Key filing fact
Eugene Bauer filed Form 4 for Evommune, Inc. on 11 Dec 2025.
Change
- Previous filing in this sequence was filed on 19 Dec 2025.
- Current net transaction value: -$26,368.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001678620
Primary reporting owner
Bauer Eugene
- Relationship
- Chief Medical Officer, Director
- Address
- C/O EVOMMUNE, INC., 1841 PAGE MILL ROAD, SUITE 100, PALO ALTO
- Signature
- /s/ Gregory S. Moss, Attorney-in-Fact
- Signature date
- 11 Dec 2025
Reported transactions
EVMN
transaction
Common Stock
Tax liability
- Transaction value
- $26,368
- Shares
- -1,478
- Change %
- -0.54%
- Price
- $17.84
- Shares after
- 270,818
- Date
- 09 Dec 2025
- Ownership
- Direct
- Footnotes
- F1
* indicates a reported price that failed the local validity check.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units. |